Benzoic acid,2-(acetyloxy)-,mixt. with 5-(2-butenyl)-5-ethyl-2,4,6(1H,3H,5H)- pyrimidinetrione and 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione (39388-19-7)

Other Product

• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2- butenyl)-5-ethyl-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 4-(dimethylamino)-1,2-dihydro-1,- 5-dimethyl-2-phenyl-3H-pyrazol-3-one
• Benzoic acid,2-(acetyloxy)-,mixt. with N-(4-ethoxyphenyl)acetamide,5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione and (RS)-R-methylbenzeneethanamine sulfate (2:1)
• Acetamide,N-(4-ethoxyphenyl)-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• Benzoic acid,compounds,sodium salt,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride, mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, 1-hexyl-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione and N,N,4-trimethyl-gamma-phenylbenzenepropanamine hydrochloride
• Ergotaman-3',6',18-trione,9,10-dihydro-12'- hydroxy-2'-methyl-5'-(phenylmethyl)-,(5'R,- 10R)-,mixt. with 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)- 2-phenyl-3H-pyrazol-3-one,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 5-(2-methylpropyl)-5-(2-propenyl)- 2,4,6(1H,3H,5H)-pyrimidinetrione
• Acetamide,N-(4-ethoxyphenyl)-,mixt. with 5,5-diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 4-(dimethylamino)-1,2-dihydro-1,- 5-dimethyl-2-phenyl-3H-pyrazol-3-one
• Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
• Benzoic acid, 2-hydroxy-, calcium salt (2:1), compd. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1), mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride and potassium iodide (KI)
• 8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8,8-dimethyl-, endo-(+-)-, nitrate (salt), mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione, 3,7-dihydro-7-(2-hydroxyethyl)-1,3-dimethyl-1H-purine-2,6-dione, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline hydrochloride and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
• 10H-Phenothiazine-10-carboxylic acid,2-(diethylamino)ethyl ester,monohydrochloride,mixt. with 2-(acetyloxy)benzoic acid,1,2-dihydro-1,5-dimethyl-2-phenyl-3Hpyrazol- 3-one,(1S,2R)-3-(dimethylamino)-2- methyl-1-phenyl-1-(phenylmethyl)propyl propanoate hydrochloride and 5-ethyl-5-(1-methyl-1-butenyl)-2,4,6(1H,- 3H,5H)-pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione compd. with 1,2-ethanediamine (2:1) and (RR)-R-[(1S)-1-(methylamino)ethyl]- benzenemethanol
• Benzenepropanaminium, gamma-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma-phenyl-, iodide, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, (S-(R*,S*))-6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-1(3H)-isobenzofuranone hydrochloride, 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione and N-(4-hydroxyphenyl)acetamide
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,- 3H,5H)-pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-5-ethyl-, mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one
• 5-Ethyl-1-methyl-5-(3-methyl-2-butenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
• Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide,5-ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione monosodium salt and 2-(phenylmethyl)-1H-benzimidazole
• Benzoic acid,2-(acetyloxy)-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and N-(4-hydroxyphenyl)acetamide